Pauline Brice

Pauline Brice

UNVERIFIED PROFILE

Are you Pauline Brice?   Register this Author

Register author
Pauline Brice

Pauline Brice

Publications by authors named "Pauline Brice"

Are you Pauline Brice?   Register this Author

100Publications

3840Reads

34Profile Views

Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients.

Cancer Immunol Immunother 2019 Sep 7. Epub 2019 Sep 7.

Sorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Inserm UMRS 1138, "Cancer, Immune Control and Escape" Laboratory, Centre de Recherche des Cordeliers, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02389-7DOI Listing
September 2019

Romidepsin is an effective and well-tolerated therapy in CD3CD4 lymphocyte-variant hypereosinophilic syndrome: A case report.

J Allergy Clin Immunol Pract 2019 May 10. Epub 2019 May 10.

Department of Clinical Immunology, Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2019.04.039DOI Listing
May 2019

L’arrivée de l’immunothérapie dans le lymphome de Hodgkin.

Bull Cancer 2018 Dec;105 Suppl 1:S50-S58

Service d'onco-hématologie - Hôpital Saint-Louis, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(18)30390-4DOI Listing
December 2018

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.

N Engl J Med 2018 09;379(10):934-947

From Université Lille, Centre Hospitalier Universitaire (CHU), Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille (F.M.), CHU Régional de Nancy, Service d'Hématologie, Vandoeuvre lès Nancy (P.F.), Institut Paoli-Calmettes (R.B.) and Department of Pathology, Institut Paoli-Calmettes, Centre de Recherche en Cancerologie de Marseille, INSERM, Centre National de la Recherche Scientifique, Aix-Marseille Université (L.X.), Marseille, Centre Henri Becquerel, Unité 1245 and Département d'Hématologie, Université de Rouen, Rouen (H.T.), Institut d'Hématologie de Basse Normandie, Caen (C.F.), CHU Le Bocage Service d'Hématologie Clinique, Dijon (R.-O.C.), Hôpital Henri Mondor Unité Hémopathies Lymphoïdes, Créteil (C.H.), Centre Hospitalier Départemental Vendée Service d'Onco-Hématologie, La Roche sur Yon (H.M.), Institut Universitaire du Cancer de Toulouse Oncopole Service d'Hématologie, Toulouse (L.Y.), CHU Bordeaux, Service d'Hématologie, Bordeaux (K.B.), Hôpital Saint Louis Service d'Onco-Hématologie, Paris (P.B.), Gustave Roussy Cancer, Villejuif (V.R.), Centre Hospitalier Annecy Genevois Service, Annecy (N.D.), CHU de Nantes-Hôtel Dieu Service d'Hématologie Clinique, Centre de Recherche en Cancerologie et Immunologie, INSERM, Centre National de la Recherche Scientifique, Université de Nantes, Nantes (S.L.G.), Centre Hospitalier Métropole Savoie Service Hématologie, Chambery (G.M.P.), Department of Hematology, CHU Montpellier, University of Montpellier, Montpellier (G.C.), and Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, University of Lyon, Pierre-Benite (G.A.S.) - all in France; the Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston (N.H.F.); the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (M.L.P.); the Department of Medicine, Division of Medical Oncology, University of Washington, Seattle (E.N.L.); Sarah Cannon Research Institute-Tennessee Oncology, Nashville (I.W.F.); Washington University School of Medicine, Siteman Cancer Center, St. Louis (N.L.B.); the Department of Hematology, Hospital Universitario de Salamanca and Instituto de Investigación Biomédica de Salamanca, Centro de Investigación Biomédica en Red de Cáncer, Salamanca (A.M.G.-S.), and the Department of Hematology, Hospital Clinic de Barcelona, Barcelona (A.L.-G.) - both in Spain; CHU de Québec, Hôpital de l'Enfant-Jésus, Quebec (J.-F.L.), and British Columbia Cancer Centre for Lymphoid Cancer, University of British Columbia, Vancouver (L.H.S.) - both in Canada; the Department of Hematology and Oncology, Tokai University Hospital, Kanagawa, Japan (K.A.); Instituto Português de Oncologia Lisboa Francisco Gentil Departamento de Hematologia, Lisbon (M.G.S.); the Department of Hematology, CHU Université Catholique de Louvain Namur, Yvoir (M.A.), and the Department of Hematology, Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp (P.Z.) - both in Belgium; the Department of Hematology, National Cancer Center Hospital, Tokyo, Japan (K.T.); and Celgene, Summit, NJ (D.L., J.W.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1805104
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1805104DOI Listing
September 2018

Prolonged remissions after anti-PD-1 discontinuation in patients with Hodgkin lymphoma.

Blood 2018 06 3;131(25):2856-2859. Epub 2018 May 3.

Department of Hematology, Centre Hospitalier Universitaire (CHU) Rennes, Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-03-841262DOI Listing
June 2018

Refractory Hodgkin lymphoma: time for targeted therapies?

Authors:
Pauline Brice

Blood 2018 03;131(11):1156-1157

Hôpital Saint Louis.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-12-824136DOI Listing
March 2018

Hodgkin lymphoma in adolescent and young adults: insights from an adult tertiary single-center cohort of 349 patients.

Oncotarget 2017 Oct 6;8(45):80073-80082. Epub 2017 Sep 6.

Department of Onco-Hematology, Hôpital Saint Louis, Assistance Publique des Hôpitaux de Paris (AP-HP), Université Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.20684DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668122PMC
October 2017

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.

J Clin Oncol 2017 Jul 25;35(19):2125-2132. Epub 2017 Apr 25.

Robert Chen, City of Hope National Medical Center, Duarte, CA; Pier Luigi Zinzani, University of Bologna, Bologna, Italy; Michelle A. Fanale, The University of Texas MD Anderson Cancer Center, Houston, TX; Philippe Armand and Margaret A. Shipp, Dana-Farber Cancer Institute, Boston, MA; Nathalie A. Johnson, Jewish General Hospital, Montreal, Canada; Pauline Brice, Hôpital Saint-Louis, Paris; Vincent Ribrag, Institut Gustave Roussy, Villejuif, France; John Radford, The University of Manchester and Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Daniel Molin, Uppsala University, Uppsala, Sweden; Theodoros P. Vassilakopoulos, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece; Akihiro Tomita, Nagoya University Graduate School of Medicine, Nagoya, Japan; Bastian von Tresckow, University Hospital Cologne, Cologne, Germany; Yinghua Zhang, Alejandro D. Ricart, and Arun Balakumaran, Merck, Kenilworth, NJ; Craig H. Moskowitz, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.72.1316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791843PMC
July 2017

Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.

J Clin Oncol 2017 Jun 14;35(16):1786-1794. Epub 2017 Mar 14.

Marc P.E. André, Université Catholique de Louvain, Yvoir; Catherine Fortpied, Valeria Fiaccadori, and Tiana Raveloarivahy, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Théodore Girinsky and Christophe Fermé, Institut Gustave Roussy, Villejuif; Oumédaly Reman, Institut d'Hématologie de Basse Normandie, Centre Hospitalier Universitaire, Caen; Pauline Brice, Assistance Publique des Hopitaux de Paris Hôpital Saint-Louis; Richard Delarue, Assistance Publique des Hopitaux de Paris Hôpital Universitaire Necker-Enfants Maladies, Paris; Olivier Casasnovas, Centre Hospitalier Universitaire le Bocage and Institut National de la Santé et de la Recherche Médicale, Dijon; Véronique Edeline, Hôpital René Hugenin-Institut Curie, Saint Cloud; Réda Bouabdallah, Institut Paoli Calmette, Marseille; Catherine Sebban, Hematology Centre Léon Bérard, Lyon; Aspasia Stamatoullas, Centre Henri Becquerel, Rouen; Michel Meignan, Henri Mondor University Hospitals, Créteil, France; Massimo Federico and Monica Bellei, University of Modena and Reggio Emilia, Modena; Manuel Gotti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia; Alessandro Re, Spedali Civili Hospital, Brescia; Francesco Merli and Annibale Versari, Arcispedale Santa Maria Nuova Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy; Richard van der Maazen and John Raemaekers, Radboud University Medical Center, Nijmegen; Gustaaf van Imhoff, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands; and Lena Specht and Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.6394DOI Listing
June 2017

Immediate hypersensitivity reaction to pegylated liposomal doxorubicin: management and outcome in four patients.

Eur J Dermatol 2017 Jun;27(3):271-274

Department of Dermatology, Saint-André Hospital CHU Bordeaux, Bordeaux, France, INSERM U1053, Bordeaux Research in Translational Oncology University Bordeaux, Bordeaux, France, French Study Group of Cutaneous Lymphoma (GFELC).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/ejd.2017.2986DOI Listing
June 2017

Lymphoma in Adolescents and Young Adults.

Prog Tumor Res 2016 5;43:101-14. Epub 2016 Sep 5.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000447080DOI Listing
April 2017

Reply to M. Lambertini et al.

J Clin Oncol 2017 03 28;35(7):805-806. Epub 2016 Nov 28.

Isabelle Demeestere, Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium; Pauline Brice, St Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Fedro A. Peccatori, European Institute of Oncology, Milan, Italy; Alain Kentos, Jolimont Hospital, Haine-Saint-Paul, Belgium; Jehan Dupuis, Henri Mondor Hospital, Paris, France; Pierre Zachee, Algemeen Ziekenhuis Stuivenberg, Antwerp, Belgium; Rene-Olivier Casasnovas, Centre Hospitalier Universitaire Dijon, Dijon, France; Eric Van Den Neste, Cliniques Universitaires Université Catholique de Louvain Saint-Luc, Brussels, Belgium; Julie Dechene, Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium; Viviane De Maertelaer, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Belgium; Dominique Bron, J. Bordet Institute, Brussels, Belgium; and Yvon Englert, Research Laboratory on Human Reproduction, Université Libre de Bruxelles, and Erasme Hospital, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.6093DOI Listing
March 2017

Fertility preservation before an ABVD protocol: no new evidence to support changing the recommendations.

Future Oncol 2017 Mar 6;13(7):589-590. Epub 2016 Dec 6.

Service d'Hématologie-Oncologie, Hôpital Saint Louis, 1 avenue Claude Vellefaux, 75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2016-0441DOI Listing
March 2017

Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma.

Strahlenther Onkol 2017 Feb 17;193(2):116-124. Epub 2016 Jun 17.

Radiation Oncology Department, Saint Louis Hospital, 1, Avenue Claude Vellefaux, 75010, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-016-0969-9DOI Listing
February 2017

[Hodgkin and non-Hodgkin lymphoma of adolescents and young adults].

Bull Cancer 2016 Dec 17;103(12):1035-1049. Epub 2016 Nov 17.

Institut Paoli-Calmettes, département d'hématologie, 232, boulevard Sainte-Marguerite, 13009 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.10.011DOI Listing
December 2016

Rituximab-ABV(D) for patients with Nodular lymphocyte predominant Hodgkin lymphoma ineligible for radiation therapy.

Br J Haematol 2016 11 18;175(4):735-737. Epub 2015 Dec 18.

Department of Haematology, APHP, Hôpital Saint-Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13879DOI Listing
November 2016

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.

J Clin Oncol 2016 08 23;34(22):2568-74. Epub 2016 May 23.

Isabelle Demeestere, Julie Dechene, Yvon Englert, and Viviane De Maertelaer, Université Libre de Bruxelles; Alain Kentos and Yvon Englert, Erasme Hospital; Eric Van Den Neste, Cliniques Universitaires UCL Saint-Luc; Dominique Bron, J. Bordet Institute, Brussels; Pierre Zachee, Algemeen Ziekenhuis Stuivenberg, Antwerpen, Belgium; Pauline Brice, St Louis Hospital, APHP; Jehan Dupuis, Hôpital Henri Mondor, Paris; Olivier Casasnovas, CHU de Dijon, Dijon, France; and Fedro A. Peccatori, Istituto Europeo di Oncologia, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.8864DOI Listing
August 2016

Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.

J Clin Oncol 2016 08 13;34(22):2575-82. Epub 2016 Jun 13.

Clémentine Sarkozy and Gilles Salles, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'Hématologie, Pierre Bénite and Université Claude Bernard, Faculté de Médecine Lyon-Sud Charles Mérieux Pierre Bénite; Luc Xerri, Aix-Marseille University and Institut Paoli-Calmettes, Marseille; Pierre Feugier, Centre Hospitalier Universitaire de Nancy and INSERM 954 Université de Lorraine, Nancy; Pauline Brice, Hôpital Saint Louis APHP and Université Paris VII; Danielle Canioni, Assistance Publique Hôpitaux de Paris (APHP) Hôpital Universitaire Necker-Enfants Malades; Richard Delarue, APHP Hôpital Universitaire Necker-Enfants Malades and Descartes-Sorbonne Paris Cité University, Paris; Pierre Soubeyran, Institut Bergonié and Université Victor Segalen Bordeaux, Bordeaux; Christiane Mounier, Institut de Cancérologie Lucien Neuwirth, Saint Priest; Jehan Dupuis, Henri Mondor University Hospital, Créteil; Hervé Tilly, Université de Rouen, Rouen, France; Marek Trneny, Charles University General Hospital, Prague, Czech Republic; Nick Wickham, University of Adelaide, Adelaide; Marlton Paula, Princess Alexandra Hospital, University of Queensland School of Medicine, Brisbane; John Seymour, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia; Sirpa Leppa, Helsinki University Hospital Cancer Center and University of Helsinki, Helsinki, Finland; Maria Gomes Da Silva, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal; Fritz Offner, Gent University, Gent; Pierre Zachee, ZNA Stuivenberg, Antwerp, Belgium; and Dolores Caballero, Universitario de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.7163DOI Listing
August 2016

Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.

J Clin Oncol 2016 06 25;34(17):2028-36. Epub 2016 Apr 25.

Patrice Carde and Christophe Ferme, Gustave Roussy Cancer Campus, Villejuif; Pauline Brice, Hopital St. Louis, Paris; Olivier Casasnovas and Denis Caillot, Centre Hospitalier Universitaire (CHU) de Dijon, Dijon; Isabelle Gaillard, CHU Henri Mondor, Creteil; Serge Bologna, Centre Hospitalier Regional Universitaire (CHR) de Nancy, Nancy; Frank Morschhauser, CHR de Lille, Lille; Bertrand Coiffier, CHU de Lyon, Lyon; Nicolas Mounier, Hopital de L'Archet, Nice, France; Matthias Karrasch and Catherine Fortpied, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Hussein Khaled, National Cancer Institute, Cairo, Egypt; Pieternella Johanna Lugtenburg, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Igor Aurer, University Hospital Centre Zagreb, Zagreb, Croatia; Ralph Meyer, Juravinski Cancer Centre, Hamilton, Ontario; Matthew Seftel, Cancer Care Manitoba, Winnipeg, Manitoba, Canada; Max Wolf, Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia; Bengt Glimelius, Uppsala University, Uppsala, Sweden; and Anna Sureda, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.5648DOI Listing
June 2016

Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma.

Onco Targets Ther 2016 6;9:2027-34. Epub 2016 Apr 6.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S96175DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827881PMC
April 2016

Brentuximab vedotin in refractory or relapsed peripheral T-cell lymphomas: the French named patient program experience in 56 patients.

Haematologica 2016 Mar 24;101(3):e103-6. Epub 2015 Dec 24.

Département de Pathologie, Groupe Henri-Mondor Albert-Chenevier, Assistance Publique - Hôpitaux de Paris, Créteil, France Unité INSERM U955, Créteil, France Université Paris Est, Créteil, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.135400DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815738PMC
March 2016

Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens.

PLoS One 2014 15;9(7):e102501. Epub 2014 Jul 15.

Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale, Paris, France; University Paris Descartes, Sorbonne Paris Cité, Imagine Institute, Paris, France; St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0102501PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099326PMC
October 2015

Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse.

Blood 2015 Oct 3;126(14):1695-8. Epub 2015 Aug 3.

Hemato-oncology Department, Assistance Publique-Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Paris, France; Paris Diderot Université, Sorbonne Paris Cité, Paris, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-05-647834DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591793PMC
October 2015

Diagnostic Yield and Safety of Computed Tomography-guided Mediastinal Core Needle Biopsies.

J Thorac Imaging 2015 Sep;30(5):319-27

Departments of *Radiology †Hematology ‡Pulmonology §Pathology, Hôpital Saint Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RTI.0000000000000160DOI Listing
September 2015

Efficacy of Vinblastine in Primary Cutaneous Anaplastic Large Cell Lymphoma.

JAMA Dermatol 2015 Sep;151(9):1030-1

Department of Dermatology, Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Paris, France7Department of Dermatology, Université Sorbonne, Paris, France.

View Article

Download full-text PDF

Source
http://archderm.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamadermatol.2015.1357DOI Listing
September 2015

PET2 -driven de-escalation therapy in 64 high-risk Hodgkin Lymphoma patients treated with escalated BEACOPP.

Br J Haematol 2015 Jul 9;170(2):278-81. Epub 2015 Jan 9.

Department of Haematology, Hôpital Saint Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13287DOI Listing
July 2015

Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies.

J Clin Oncol 2015 May 30;33(13):1482-90. Epub 2015 Mar 30.

Jennifer L. Kelly and Jonathan W. Friedberg, James P. Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, NY; Gilles Salles, Hospices Civils de Lyon, Université Claude Bernard Lyon-1, Pierre Benite; Pauline Brice, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris; Olivier Casasnovas, Centre Hospitalo-Universitaire de Dijon, Dijon; Pierre Soubeyran, Institut Bergonié and Université Victor Segalen Bordeaux 2, Bordeaux; Corinne Haioun, Assistance Publique-Hôpitaux de Paris, Hôpital Henri Mondor, Créteil; Luc Xerri, Institut Paoli Calmettes, Marseille; Hervé Tilly, Centre Henri Becquerel, Rouen, France; Bryan Goldman, Oliver Press, and Michael LeBlanc, SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA; Richard I. Fisher, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, PA; and Lisa Rimsza, University of Arizona, Tucson, AZ.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/03/30/JCO.2014.57
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.57.5092
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.5092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404425PMC
May 2015

Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma.

Eur J Nucl Med Mol Imaging 2014 Nov 26;41(11):2023-30. Epub 2014 Jun 26.

AP-HP- Hôpital Européen Georges Pompidou, Service de médecine nucléaire, Paris, 75015, France,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-014-2825-4DOI Listing
November 2014

Sarcoidosis occurring after lymphoma: report of 14 patients and review of the literature.

Medicine (Baltimore) 2014 Nov;93(21):e121

Department of Internal Medicine (JL, CLL, LG, NC-C, LM, BT), National Referral Center for Rare Systemic and Autoimmune Diseases; Department of Hematology (BD), Cochin Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Descartes; Department of Hematology (EC); Department of Internal Medicine (CC-A), Pitié-Salpêtrière Hospital, AP-HP; Department of Onco-Hematology (PB), Saint-Louis Hospital, AP-HP; Department of Pathology (BB), Hôtel-Dieu Hospital, AP-HP; Department of Thoracic Surgery (MA), Cochin Hospital, AP-HP, Paris; Department of Internal Medicine (AC, FM), Belle Isle Hospital, Metz; Department of Internal Medicine (AG, NS), CHU Conception, Assistance Publique-Hôpitaux de Marseille, Marseille; Department of Medicine (CF), Gustave Roussy, Villejuif; and Lymphoid Malignancies Unit (CH), Henri Mondor Hospital, AP-HP, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000000121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616278PMC
November 2014

Four cases of rituximab-associated melanoma.

Melanoma Res 2014 Aug;24(4):401-3

Departments of aDermatology bHemato-oncology cAnatomo-pathology, Saint Louis Hospital, Paris Cedex 10, France.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/melanomaresearch/9000/00000/Fou
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CMR.0000000000000074DOI Listing
August 2014

Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.

J Clin Oncol 2014 Apr 17;32(12):1188-94. Epub 2014 Mar 17.

John M.M. Raemaekers and Richard van der Maazen, Radboud University Medical Center, Nijmegen; Pieternella J. Lugtenburg, Erasmus University Medical Center, Rotterdam; Gustaaf van Imhoff, University Medical Centre Groningen, Groningen, the Netherlands; Marc P.E. André and Thierry van der Borght, Centre Hospitalier Universitaire (CHU) L'Université Catholique de Louvain Mont Godinne, Yvoir; Yolande Lievens, Ghent University Hospital, Ghent; Tiana Raveloarivahy and Catherine Fortpied, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Massimo Federico and Monica Bellei, University of Modena and Reggio Emilia, Modena; Ercole Brusamolino, Istituto Clinico Humanitas, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan; Manuel Gotti, Fondazione IRCCS Policlinico San Matteo, Pavia; Allessandro Re, Spedali Civili Hospital, Brescia; Elisabetta Abruzzese, San Eugenio Hospital, Tor Vergata University, Rome; Annibale Versari, Arcispedale Santa Maria Nuova, IRCCS di Reggio Emilia, Reggio Emilia, Italy; Theodore Girinsky and Christophe Fermé, Institut Gustave Roussy, Villejuif; Reman Oumedaly, CHU Caen; Stephane Bardet, Centre Francois Baclesse, Caen; Pauline Brice, Hôpital Saint-Louis, Paris; Reda Bouabdallah, Institut Paoli Calmette, Marseille; Catherine J. Sebban, Centre Léon Bérard, Lyon; Aspasia Stamatoullas, Centre Henri Becquerel, Rouen; Frank Morschhauser, CHU de Lille, Lille; Pierre Olivier, CHU Nancy, Nancy; Rene-Olivier Casasnovas, CHU de Dijon, Dijon; Michel Meignan, Hôpital Henri Mondor, Creteil, France; and Martin Hutchings, Rigshospitalet, Kopenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.9298DOI Listing
April 2014

[News in hodgkin lymphoma therapy].

Authors:
Pauline Brice

Bull Cancer 2014 Jan;101(1):68-74

Hôpital Saint-Louis, 1, avenue Claude-Vellefeaux 75475 Paris Cedex 10, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2013.1877DOI Listing
January 2014

Autoimmune hemolytic anemia and nodular lymphocyte-predominant hodgkin lymphoma: a rare association.

Case Rep Hematol 2013 28;2013:567289. Epub 2013 Apr 28.

Department of Hematology, Hôpital Universitaire Necker-Enfants Malades and Assistance Publique-Hôpitaux de Paris (AP-HP), 149 Rue de Sèvres, 75015 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/567289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655493PMC
May 2013

Therapy-related classical Hodgkin lymphoma after a primary haematological malignancy: a report on 13 cases.

Br J Haematol 2012 Sep 26;158(5):644-8. Epub 2012 Jun 26.

Department of Haemato-Oncology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris 7-Diderot, Paris, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2141.2012.09202.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2141.2012.09202.xDOI Listing
September 2012

(18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging.

Eur J Nucl Med Mol Imaging 2010 Jun 4;37(6):1095-105. Epub 2010 Mar 4.

Service de Médicine Nucléaire, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université Paris 7, 1, avenue Claude Vellefaux, 75475, Paris cedex 10, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-009-1377-5DOI Listing
June 2010

Cost effectiveness of rituximab maintenance therapy in follicular lymphoma: long-term economic evaluation.

Pharmacoeconomics 2010 ;28(1):35-46

INSERM U-645, Université de Franche-Comté, Hematology-CHU Jean Minjoz, Besançon, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.2165/11314070-000000000-00000
Publisher Site
http://dx.doi.org/10.2165/11314070-000000000-00000DOI Listing
February 2010